ABSTRACT Background: Animal models have shown that adipose-derived palmitoleic acid may serve as a lipokine that contributes to resistance to diet-induced obesity. Studies in humans have evaluated only plasma palmitoleic acid concentrations, which reflect stearoylcoenzyme A desaturase 1 (SCD1) activity in the liver and are associated with increased risk of obesity. These apparent opposite effects of palmitoleic acid deserve further research in humans. Because carbohydrate intake can increase hepatic SCD1 activity, it could be used as a stratifying variable to disentangle the effects of adipose tissue SCD1 compared with the effects of liver SCD1 activity on obesity. Objective: We examined whether the effects of adipose tissue palmitoleic acid and SCD1 activity were associated with decreased obesity prevalence and whether this association was modified by carbohydrate intake. .30] were examined in a cross-sectional study in 1926 adults in Costa Rica. Two desaturation indexes (16:1/16:0 and 18:1/18:0) were used as surrogate measures of adipose tissue SCD1 activity. Results: We observed a positive association between adipose tissue palmitoleic acid concentrations and obesity (PR for lowest compared with highest quintiles of palmitoleic acid: 2.27; 95% CI: 1.52, 3.38; P for trend , 0.0001). A significant association was also observed between obesity and adipose desaturation indexes. The association between adipose tissue palmitoleic acid concentrations and obesity was attenuated in persons with low carbohydrate intake. Conclusions: There is no direct evidence that adipose tissue palmitoleic acid behaves as a lipokine to reduce obesity occurrence in humans. However, the attenuation of the association by low carbohydrate intake warrants further research on adipose-derived palmitoleic acid and obesity risk.
INTRODUCTION
Obesity is a worldwide health concern (1) and is caused by an imbalance between energy intake and energy expenditure that results in fat storage (2) . It is known that stearoyl-coenzyme A desaturase (SCD) enzymes affect fat storage (3, 4) . SCD enzymes are involved in de novo synthesis of monounsaturated fatty acids from saturated fatty acids (5) . The major products of SCD are palmitoleic acid (16:1) and oleic acid (18:1), which are key substrates for the formation of triglycerides (5) , from its preferred substrates, palmitic acid (16:0) and stearic acid (18:0) . Two SCD isoforms have been observed in humans, SCD1 (primarily observed in adipose tissue and the liver) and SCD5 (observed in the brain and pancreas) (6) (7) (8) .
Because of the difficulties of directly measuring SCD1 activity in humans, SCD1 activity is proxied by the use of its product: substrate ratios (ie, desaturation indexes) including the ratio of palmitoleic acid (16:1) to palmitic acid (16:0) concentrations and the ratio of oleic acid (18:1) to stearic acid (18:0) concentrations (9, 10) . Results from animal and human studies suggest that SCD1 activity and its products may play an important role in obesity (9, (11) (12) (13) (14) (15) (16) (17) (18) (19) . SCD1-defficent mice are protected against diet-induced obesity (11) (12) (13) , and high SCD1 activity is related to obesity in animal models (14) (15) (16) (17) . Similarly, plasma palmitoleic acid concentrations and SCD1 activity are positively associated with hypertriglyceridemia, abdominal adiposity, and obesity in humans (9, 18, 19) . In contrast, Cao et al (20) recently showed in their genetic mouse model (ie, mice deficient in adipose tissue lipid chaperones aP2 and mal1) that palmitoleic acid produced and released by adipose tissue may serve as a lipokine that contributes to resistance to diet-induced obesity and improvement in insulin sensitivity. Although findings in this specific mouse model may not be translated into humans, these apparent opposite effects of palmitoleic acid warrant further research in humans.
In previous human studies that have examined risk of obesity in relation to levels of SCD1 activity and palmitoleic acid concentrations, desaturation indexes and palmitoleic acid concentrations were derived by using blood samples, which cannot address the possible different roles that liver and adipose tissue play in the development of obesity. The purpose of this study was to use adipose tissue from a population-based study in Costa Rica to test the hypothesis that adipose tissue palmitoleic acid and desaturation indexes of SCD1 activity (16:1/16:0 and 18:1/18:0, respectively) are associated with a decreased prevalence of obesity. Compared with adipose tissue, the liver has a unique ability to dramatically increase fatty acid synthesis in response to changes in dietary carbohydrate intake (2), and carbohydrates can increase hepatic SCD1 activity (12, 21) . Thus, we also examined whether carbohydrate intake modified the association between palmitoleic acid concentrations and obesity.
SUBJECTS AND METHODS

Study population
The participants in this study were control subjects from a case-control study conducted in the Central Valley in Costa Rica from 1994 to 2004 (22, 23) . Control subjects were randomly selected by matching first cases of nonfatal acute myocardial infarction on the basis of age (65 y), sex, and area of residence (county) from information available from the National Census and Statistics Bureau of Costa Rica. The final participation rate for control subjects was 88%. The general characteristics of the study population according to obesity status are shown in Table 1 .
All subjects provided written informed consent to participate in the study. The study was approved by the Human Subjects Committee of the Harvard School of Public Health and the University of Costa Rica.
Data collection
Trained personnel visited all study participants at their homes for collecting information on their sociodemographic characteristics, medical histories, and smoking-related data by the use of a questionnaire with closed-ended questions. Anthropometric measurements were collected by fieldworkers with subjects wearing light clothing and without shoes. All measurements were performed in duplicate, and the average of measurements was used for all analyses. A steel anthropometer and a bathroom scale (Detecto, Webb City, MO) or a Seca Alpha Model 770 digital scale (Seca, Hanover, MD) accurate to 50 g were used to measure height and weight respectively. The 2 scales were calibrated biweekly. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters. Self-reported dietary intake was collected through a food-frequency questionnaire that was developed and specifically validated to assess fatty acid intake in the Costa Rican population (24) . Biological specimens were collected in the morning at the homes of subjects after an overnight fast as described in detail elsewhere (23) . A subcutaneous adipose tissue biopsy was collected from the upper buttock with a 16-gauge needle and disposable syringe following procedures previously described (25) . Samples were stored in nitrogen tanks at 280°C.
Fatty acid analysis
Fatty acids from adipose tissue were quantified by gas-liquid chromatography as described previously (26) . Peak retention times and area percentages of total fatty acids were identified by injecting known standards (NuChek Prep; Nuchek, Elysian, MN) and analyzed with Agilent Technologies ChemStationA.08.03 software (Agilent Technologies, Santa Clara, CA). Twelve duplicate samples, which were indistinguishable from the others, were analyzed throughout the study. The CVs for palmitoleic acid, palmitic acid, oleic acid, and stearic acid were 5.7%, 2.9%, 2.4% and 7.7%, respectively.
Data analyses
The original sample size was composed of 2274 subjects. After eliminating control subjects with missing values on BMI, adipose tissue fatty acids, and potential confounders, a total of 1926 participants remained in the analyses. t Tests for continuous variables and chi-square tests for categorical variables were used to assess differences in means or distributions of lifestyle and other variables for subjects with obesity (BMI .30) and without obesity. Log-Poisson models with generalized estimating equations (27) were built to calculate the prevalence ratios (PRs) and 95% CIs of obesity according to quintiles of palmitoleic acid concentrations and SCD1 activity in adipose tissue. Two desaturation indexes were used to measure SCD1 activity in adipose tissue: the ratio of oleic acid to stearic acid concentrations in adipose tissue and the ratio of palmitoleic to palmitic acid concentrations in adipose tissue. Potential confounding factors, which were previously shown to be risk factors for obesity and were also correlated with adipose palmitoleic acid concentrations and desaturation indexes were entered in generalized linear models that included age, sex, annual household income, cigarette smoking [5 categories: never, past smoker, current smoker (,10 cigarettes/d), current smoker (10 and ,20 cigarettes/d), current smoker (20 cigarettes/d), fatty acids in adipose tissue (eg, arachidonic acid, a-linolenic acid, and linoleic acid), physical activity, and total energy intake. Stratified analyses were carried out in the association between adipose tissue palmitoleic acid and the prevalence of obesity according to tertiles of glucose, starch, and carbohydrate intakes expressed separately as a percentage of total energy. Generalized score tests were computed to examine the interactive effects of carbohydrate intake and palmitoleic acid concentrations in adipose tissue on obesity. All analyses were carried out with SAS software (version 9.2; SAS Institute, Cary, NC).
RESULTS
A total of 340 subjects (17.7% of the study population) met the criterion for obesity. Obese subjects were more likely to be women but less likely to be smokers or to be physically active compared with nonobese subjects. In addition, obese subjects had significantly higher concentrations of palmitoleic acid and desaturation indexes in adipose tissue compared with those of individuals without obesity (all P values , 0.001) ( Table 1) .
As shown in Table 2 , in nonobese individuals (n = 1586), percentages of women and concentrations of arachidonic acid in adipose tissue increased across quintiles of palmitoleic acid concentrations. Adipose tissue concentrations of a-linolenic acid and linoleic acid decreased across quintiles of palmitoleic acid concentrations. Similar findings were observed when we evaluated the role of potential confounders across quintiles of desaturation indexes (16:1/16:0 and 18:1/18:0) in adipose tissue (data not shown).
The associations between palmitoleic acid concentrations and SCD1 activity in adipose tissue and the prevalence of obesity are shown in Table 3 . PRs of obesity increased across quintiles of palmitoleic acid concentrations (P for trend , 0.001). In the multivariate adjusted models, this association remained significant [PR of the lowest quintile compared with the highest quintile of palmitoleic acid concentrations: 2.27 (95% CI: 1.52, 3.38); P for trend , 0.0001]. A similar significant association between desaturation indexes and the prevalence of obesity was observed. Compared with subjects in the lowest quintile of the desaturation index 16:1/16:0 in adipose tissue, the PR for those in the highest quintile was 3.64 (95% CI: 2.54, 5.20; P for trend , 0.001), and this relation remained significant in the multivariable adjusted model (PR: 2.38, 95% CI: 1.60, 3.53; P for trend , 0.0001). Results were similar for the desaturation index 18:1/18:0 in adipose tissue (Table 3) .
We carried out a stratified analysis of the association between adipose tissue palmitoleic acid concentrations and the prevalence of obesity according to tertiles of carbohydrate intake ( Table 4) . We used the stratification by carbohydrate intake as an indirect way to disentangle the effects of adipose-derived compared with liver-derived palmitoleic acid in adipose tissue with the assumption that, at low intakes of carbohydrates, the proportion of liver-derived palmitoleic acid is lower in adipose tissue than at high intakes of carbohydrates. In individuals with a high carbohydrate intake, increasing palmitoleic acid concentrations in adipose tissue was associated with increasing PRs for obesity. However, the PRs for obesity with increasing palmitoleic acid concentrations in adipose tissue at low carbohydrate intakes were attenuated (generalized score test; P for interactive effects = 0.15) ( Table 4 ). We also stratified by different types of carbohydrate intake (glucose and starch). The PRs for obesity with increasing palmitoleic acid concentrations in adipose tissue were also attenuated at low glucose intakes (generalized score test; P for interactive effects = 0.02) ( Table 5) . Results for starch show no significant interaction, although there was still an attenuation of the association in people in the low-starch intake group (generalized score test; P for interactive effects = 0.67).
DISCUSSION
In this population-based cross-sectional study, we observed a strong positive association between adipose tissue concentrations of palmitoleic acid and the occurrence of obesity. A similar significant association was observed between obesity and the 2 desaturation indexes (16:1/16:0 and 18:1/18:0) in adipose tissue.
Our findings were consistent with the results of other investigations in humans. In a study of 134 healthy men, abdominal adiposity was positively associated with plasma concentrations of palmitoleic acid (18) . In a study of 849 Swedish men and women, the desaturation index (16:1/16:0) derived from blood samples was associated with the prevalence of obesity (9) . Therefore, adipose tissue concentrations of palmitoleic acid and SCD1 activity likely play a positive role in the development of obesity.
However, in their genetic mouse model, Cao et al (20) showed that palmitoleic acid produced and released by adipose tissue mediates the communication between adipose tissue and other tissues and inhibits SCD1 activity in the liver, which contributes to the resistance to diet-induced obesity and enhanced insulin sensitivity. Because of the relevance of this finding in an animal model, our goal was to examine whether adipose tissue palmitoleic acid would behave similarly in humans, even if many findings in animal models have little or no relevance to metabolic mechanisms in humans. Palmitoleic acid is virtually absent in commonly consumed foods and is primarily biosynthesized from palmitic acid by the SCD1 in liver and adipose tissue (18) . In the liver, palmitoleic acid is used in the formation of triglycerides, packaged in very-low-density lipoprotein, and secreted into the blood (5). Adipose cells can take up these triglycerides from very-low-density lipoprotein by the action of lipoprotein-lipase on the lining cells of the capillaries in adipose tissue (5) . Hence, palmitoleic acid and desaturation indexes in adipose tissue may reflect the metabolic activity of the liver and adipose tissue. Previous animal and human studies have reported a positive association between hepatic SCD1 activity and obesity (2, 3, 9) . On the basis of our results, it is possible that adipose tissue palmitoleic acid may mainly reflect the palmitoleic acid that is synthesized and released by the liver instead of by adipose tissue, and the 2 adipose desaturation indexes may chiefly reflect SCD1 activity in the liver. Compared with adipose tissue, the liver has a unique ability to dramatically increase fatty acid synthesis in response to changes in dietary carbohydrate intake (2) . Studies have shown that dietary carbohydrates can robustly increase hepatic SCD1 activity (12, 21) . Thus, it is possible that dietary carbohydrate intake may alter the proportion of liver-generated palmitoleic acid in adipose tissue, which may affect the association between adipose palmitoleic acid concentrations and obesity. In the stratified analysis of the association between adipose tissue palmitoleic acid concentrations and the prevalence of obesity by tertiles of carbohydrate intake (Table 4) , we observed that the PRs of obesity for high compared with low palmitoleic acid concentrations were attenuated with decreased carbohydrate intake. Because the metabolic effects of carbohydrate intake are influenced by carbohydrate mass as well as carbohydrate components (28, 29) , we also performed stratified analyses by glucose and starch intakes. The positive association of adipose tissue palmitoleic acid and obesity was attenuated in people in the lower tertile of glucose intake and to a lesser extent in the lower tertile of starch intake (Table 5 ). We speculate that a possible explanation for this phenomenon would be that the proportion of liver-generated palmitoleic acid in adipose tissue would be lower at low intakes of carbohydrates (and mostly because of glucose), and an increased proportion of adipose-generated palmitoleic acid would attenuate the PR of obesity. Our results suggest that it is not possible to completely disentangle the effects of liver and adipose tissue SCD1 activities only by measuring adipose tissue palmitoleic acid concentrations or desaturation indexes in observational studies. Consistent with these findings, a study performed in healthy Swedish men aged from 62 to 64 y showed that adipose tissue desaturation indexes of SCD1 (16:1/16:0 and 18:1/18:0) reflected SCD1 expression in that tissue but were associated with increased insulin resistance (10) . The strengths of this study include its large sample size, the high participation rate, inclusion of a representative sample of the Costa Rican population, and the unique availability of adipose tissue measurements. Nevertheless, our observational study has several limitations. Palmitoleic acid concentrations in adipose tissue cannot be differentiated between adipose-derived and liverderived palmitoleic acid. Because of the difficulty of directly measuring SCD1 activity, we inferred SCD1 activity by the use of product:substrate ratios as previously done (9, 18, 19) . The surrogate estimates for SCD1 activity also could not distinguish between liver and adipose tissue SCD1 activity. Thus, methods that could be applied to measure adipose-derived palmitoleic acid concentrations and the exact adipose SCD1 activity need to be developed in the future to directly evaluate their effects on risk of obesity or other metabolic disorders.
In conclusion, on the basis of our data, there is no direct evidence that adipose tissue palmitoleic acid could behave as a lipokine that reduces the occurrence of obesity in humans. However, the attenuated correlation between adipose palmitoleic acid concentrations and obesity in the low dietary carbohydrateintake group is of interest and warrants further research on the effects of dietary carbohydrates and adipose-derived palmitoleic acid on obesity.
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